Abstract:Establishing reliable and reproducible animal models for disease modelling, drug screening and the understanding of disease susceptibility and pathogenesis is critical. However, traditional animal models differ significantly from humans in terms of physiology, immune response, and pathogenesis. As a result, it is difficult to translate laboratory findings into biomedical applications. Although several animal models with human chimeric genes, organs or systems have been developed in the past, their limited engraftment rate and physiological functions are a major obstacle to realize convincing models of humans. The lack of human transplantation resources and insufficient immune tolerance of recipient animals are the main challenges that need to be overcome to generate fully humanized animals. Recent advances in gene editing and pluripotent stem cell-based xenotransplantation technologies offer opportunities to create more accessible human-like models for biomedical research. In this article, we have combined our laboratory expertise to summarize humanized animal models, with a focus on hematopoietic/immune system and liver. We discuss their generation strategies and the potential donor cell sources, with particular attention given to human pluripotent stem cells. In particular, we discuss the advantages, limitations and emerging trends in their clinical and pharmaceutical applications. By providing insights into the current state of humanized animal models and their potential for biomedical applications, this article aims to advance the development of more accurate and reliable animal models for disease modeling and drug screening.

Embryo-Engineered Nonhuman Primate Models: Progress and Gap to Translational Medicine

CRISPR/Cas9-mediated genome editing in nonhuman primates

Paving the Road for Biomedicine: Genome Editing and Stem Cells in Primates

Primate Stem Cells: Bridge the Translation from Basic Research to Clinic Application

CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection

Opportunities and challenges in modeling human brain disorders in transgenic primates

Developing Humanized Animal Models with Transplantable Human iPSC-Derived Cells

Non-Human Primate Models of Enteric Viral Infections

Current Status of Synthetic Mammalian Embryo Models

Primate models for cardiovascular drug research and development.

Human disease models in drug development

The Essential Factors of Establishing Patient-derived Tumor Model.

Opportunities and limitations of genetically modified nonhuman primate models for neuroscience research

Genetically Modified Non-Human Primate Models for Research on Neurodegenerative Diseases.

Non-human Primate Models for Brain Disorders – Towards Genetic Manipulations Via Innovative Technology

In vivo whole brain, cellular and molecular imaging in nonhuman primate models of neuropathology

Advances in Pig Models of Human Diseases

Update on Hematopoietic Stem Cell Gene Transfer Using Non-Human Primate Models.

Genetically Engineered Pig Models of Neurological Diseases

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Use of rodents as models of human diseases